MyFinsight
Home
Blog
About
Tharimmune, Inc. (THAR)
Tharimmune, Inc. (THAR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$5,368,360
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Proceeds from issuance of common...
Stock based compensation
Others
Negative Cash Flow Breakdown
Net loss
Payment of deferred offering cos...
Accrued expenses
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
-2,101,838
-4,396,857
Write-off of deferred offering costs
92,168
-
Stock based compensation
527,014
778,562
Stock issuance pursuant to services agreement
-
0
Stock issuance pursuant to termination agreement
0
8,253
Prepaid expenses and other current assets
-106,980
150,755
Accounts payable
-111,356
-4,571
Accrued expenses
-368,137
-66,163
Net cash used in operating activities
-1,855,169
-3,831,531
Proceeds from issuance of common stock upon private investment in public equity offerings
1,225,003
2,500,000
Proceeds from issuance of common stock upon registered direct public offerings
7,090,014
-
Proceeds from issuance of common stock upon at-the-market offerings
0
266,625
Payment of deferred offering costs
952,725
272,246
Proceeds from insurance premium financing liability
0
285,178
Repayment of insurance premium financing liability
50,164
200,638
Repayment of note payable
88,599
64,769
Net cash provided by financing activities
7,223,529
2,514,150
Net cash provided by (used in) investing activities
-
0
Net increase (decrease) in cash
5,368,360
-1,317,381
Cash and cash equivalents at beginning of period
3,559,361
-
Cash and cash equivalents at end of period
7,610,340
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock upon...
$7,090,014
Proceeds from issuance of
common stock upon...
$1,225,003
Net cash provided by
financing activities
$7,223,529
Canceled cashflow
$1,091,488
Net increase
(decrease) in cash
$5,368,360
Canceled cashflow
$1,855,169
Payment of deferred
offering costs
$952,725
Repayment of note payable
$88,599
Repayment of insurance
premium financing...
$50,164
Stock based
compensation
$527,014
Prepaid expenses and
other current assets
-$106,980
Write-off of deferred
offering costs
$92,168
Net cash used in
operating activities
-$1,855,169
Canceled cashflow
$726,162
Net loss
-$2,101,838
Accrued expenses
-$368,137
Accounts payable
-$111,356
Buy us a coffee